Legal Representation
Attorney
Erica Halstead
USPTO Deadlines
Next Deadline
1803 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-07-09)
Due Date
July 09, 2030
Grace Period Ends
January 09, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
30 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 28, 2025 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Feb 10, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Feb 9, 2025 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Jan 10, 2025 | FINV | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Dec 20, 2024 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Dec 20, 2024 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Oct 10, 2024 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jul 14, 2024 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Jul 9, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 9, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 23, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 23, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 10, 2024 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Apr 10, 2024 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Apr 3, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 20, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 14, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 14, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 14, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 24, 2023 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Sep 27, 2023 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Sep 27, 2023 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Sep 12, 2023 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Sep 11, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 10, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 10, 2023 | CRCV | M | CORRECTION TRANSACTION RECEIVED FROM IB | Loading... |
| Aug 11, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Aug 7, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 6, 2023 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Jul 21, 2023 | SDRC | M | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, pharmaceutical preparations for treatment of fatty liver and steatohepatitis, pharmaceutical preparations for the treatment of cardiovascular disorders and metabolic disorders, pharmaceutical preparations for the treatment of digestive system disease, pharmaceutical preparations for the treatment of primary biliary cirrhosis, pharmaceutical preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosis, pharmaceutical preparations for the treatment of liver disease, pharmaceutical preparations for the treatment of metabolic disease, pharmaceutical preparations for the prevention and treatment of disorders of the metabolic system, analgesics; pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; veterinary preparations, namely, veterinary preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, veterinary preparations for treatment of fatty liver and steatohepatitis, veterinary preparations for the treatment of cardiovascular disorders and metabolic disorders, veterinary preparations for the treatment of digestive system disease, veterinary preparations for the treatment of primary biliary cirrhosis, veterinary preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosis, veterinary preparations for the treatment of liver disease, veterinary preparations for the treatment of metabolic disease, veterinary preparations for the prevention and treatment of disorders of the metabolic system, analgesics; veterinary pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; veterinary pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; sanitary preparations for medical use; anti-inflammatory agents, namely, topical preparations in the form of gels and salves, adhesive skin patches, liquid formulations, cream and sprays, all for relieving pain
Additional Information
Design Mark
The mark consists of two incomplete shaded rectangular shapes in green, with a puzzle like circular cut out in the center of the two rectangles; on the left rectangle is a dark blue shaded circle in the center, a light blue circle in the center of the dark blue circle and a green oval design at the center of the light blue circle; the rectangle on the left contains four white circles indicating reflecting light; the overall rectangular design appears in fading shades of green and white; the color gray appears as shadowing around the mark.
Color Claim
The color(s) green, dark blue, light blue, white and gray is/are claimed as a feature of the mark.
Other
The colors green, gray, white, blue and dark blue are claimed as a feature of the mark; the mark consists of two incomplete shaded rectangular shapes in green, with a puzzle like circular cut out in the center of the two rectangles, on the left rectangle is a dark blue shaded circle in the center and a lighter blue circle in the center of the darker circle, the rectangle on the left contains four white circles indicating reflecting light, and the entire design contains a gray shadow.
Classification
International Classes
005